A New Scoring Algorithm to Assess the Prognosis of Primary and Metastatic Breast Cancer with HER2-low Expression

被引：0
|
作者：
Miao, Jiaxian [1 ]
Shang, Jiuyan [1 ]
Liu, Yueping [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
187
引用
收藏
页码：S222 / S224
页数：3
相关论文
共 50 条
  • [31] The dynamics of HER2-low expression during breast cancer progression
    Anderson, Sarah
    Bartow, Brooke Baxter
    Siegal, Gene P.
    Huang, Xiao
    Wei, Shi
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (03) : 437 - 446
  • [32] The dynamics of HER2-low expression during breast cancer progression
    Sarah Anderson
    Brooke Baxter Bartow
    Gene P. Siegal
    Xiao Huang
    Shi Wei
    Breast Cancer Research and Treatment, 2023, 201 : 437 - 446
  • [33] Her2-low breast cancer: prevalence rate and scoring concordance among pathologists
    Al-Jussani, G.
    Salem, A.
    Mullahuwash, Y.
    Alsamarat, F.
    Abuquteish, D.
    Sughayer, M. A.
    VIRCHOWS ARCHIV, 2024, 485 : S51 - S51
  • [34] HER2-low breast cancer: a new concept in breast cancer treatment strategy
    Deluche, Elise
    Vincent-Salomon, Anne
    BULLETIN DU CANCER, 2021, 108 (11) : S1 - S7
  • [35] Safety and Efficacy of Trastuzumab Deruxtecan for Metastatic HER2+and HER2-low Breast Cancer
    Qureshi, Zaheer
    Altaf, Faryal
    Jamil, Abdur
    Siddique, Rimsha
    Fatima, Eeshal
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (11): : 535 - 541
  • [36] ERBB2 mRNA expression in HER2-low breast cancer
    Teng, X.
    Li, X.
    Xu, S.
    Zhang, J.
    Bai, Y.
    Ba, X.
    Wu, Z.
    Liu, S.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S93 - S93
  • [37] The Exciting New Field of HER2-Low Breast Cancer Treatment
    Eiger, Daniel
    Agostinetto, Elisa
    Saude-Conde, Rita
    de Azambuja, Evandro
    CANCERS, 2021, 13 (05) : 1 - 18
  • [38] The association between HER2-low expression and prognosis of breast cancer: a systematic review and meta-analysis
    Tang, Yuyao
    Shen, Guoshuang
    Xin, Yuanfang
    Li, Zhoujuan
    Zheng, Yonghui
    Wang, Miaozhou
    Liu, Zhen
    Zhao, Yi
    Zhao, Fuxing
    Ren, Dengfeng
    Zhao, Jiuda
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [39] The association between HER2-low expression and prognosis of breast cancer: a systematic review and meta-analysis
    Tang, Yuyao
    Shen, Guoshuang
    Xin, Yuanfang
    Li, Zhoujuan
    Zheng, Yonghui
    Wang, Miaozhou
    Liu, Zhen
    Zhao, Yi
    Zhao, Fuxing
    Ren, Dengfeng
    Zhao, Jiuda
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [40] HER2-Low Expression in Metastatic Breast Cancer: Discordance in Patients with both Cytology and Surgical Pathology Specimens
    Glasgow, Akisha
    VanderLaan, Paul
    Collins, Laura
    Quintana, Liza
    LABORATORY INVESTIGATION, 2023, 103 (03) : S302 - S303
12345